ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 632,08
1,24%
Dow Jones
39 308,00
-0,06%
DAX
18 374,53
1,22%
Brent Oil
86,91
0,54%
Bitcoin
60 249,85
-2,86%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Trius Therapeutics, Inc. (MM) (TSRX)

  7. Trius Therapeutics, Inc. (MM) (TSRX) Actualités

TSRX

Trius Therapeutics, Inc. (MM) (TSRX)

Trius Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TSRX
DateHeureSourceTitreSymboleSociété
14/02/201421h15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
10/10/201321h54Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
23/09/201315h35Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
17/09/201312h00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
14/09/201300h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
13/09/201322h03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
13/09/201322h03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
13/09/201322h02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
11/09/201323h11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
11/09/201323h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
11/09/201323h08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
11/09/201322h30Business WireCubist Pharmaceuticals Completes Acquisition of Trius TherapeuticsNASDAQ:TSRXTrius Therapeutics, Inc. (MM)
11/09/201322h26Edgar (US Regulatory)(25-NSE)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
11/09/201317h00Business WireCubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius TherapeuticsNASDAQ:TSRXTrius Therapeutics, Inc. (MM)
06/09/201322h01GlobeNewswire Inc.Trius Therapeutics to Present Data From Antibiotics Development Programs at ICAAC 2013NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
29/08/201322h00Business WireCubist Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of TriusNASDAQ:TSRXTrius Therapeutics, Inc. (MM)
13/08/201316h18Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
13/08/201316h08Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
07/08/201322h47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
06/08/201322h00GlobeNewswire Inc.Trius Therapeutics Reports Second Quarter 2013 Financial ResultsNASDAQ:TSRXTrius Therapeutics, Inc. (MM)
06/08/201318h44PR Newswire (US)SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Trius Therapeutics, Inc. - TSRXNASDAQ:TSRXTrius Therapeutics, Inc. (MM)
05/08/201314h00PR Newswire (US)Strategic Initiatives, Executive Transitions, and Strengthened Portfolios to Increase Shareholder Value - Research Report on ...NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
02/08/201317h14Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
01/08/201321h12Business WireInvestigations into Proposed Buyouts of Optimer Pharmaceuticals, Inc., Trius Therapeutics, Inc. & Maidenform Brands, Inc. Ann...NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
01/08/201317h20Business WireTRIUS THERAPEUTICS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Trius The...NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
01/08/201316h53PR Newswire (US)Ryan & Maniskas, LLP Announces Investigation of Trius Therapeutics, Inc.NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
01/08/201314h00Business WireFaruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Trius Therapeutics, Inc. Over the Proposed Sale...NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
01/08/201303h54Business WireTRIUS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Trius Ther...NASDAQ:TSRXTrius Therapeutics, Inc. (MM)
31/07/201321h16PR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Trius Therapeutics, Inc. - TSRXNASDAQ:TSRXTrius Therapeutics, Inc. (MM)
31/07/201319h48Business WireRigrodsky & Long, P.A. Announces Investigation Of Trius Therapeutics, Inc. BuyoutNASDAQ:TSRXTrius Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:TSRX

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
EU
PX1
CAC 40
EU
RNO
Renault
NASDAQ
AAPL
Apple
EU
LR
Legrand
EU
HO
Thales
EU
CAP
Capgemini
EU
SGO
Cie de SaintGobain
EU
BEL20
Bel 20
EU
ORA
Orange
COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
EU
VK
Vallourec
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés